2023 annual financial data
MIRA Pharmaceuticals 2023 Operating cash flow growth
Direct answer
Operating cash flow growth was 19.13%.
Operating income was -8,526,049 USD and net income was -11,982,343 USD.
Operating cash flow was -4,532,403 USD.
Get free MIRA Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,526,049 USD
- Net income
- -11,982,343 USD
- Operating cash flow
- -4,532,403 USD